[ASAP] Discovery and Optimization of Triazolopyrimidinone Derivatives as Selective NLRP3 Inflammasome Inhibitors

ACS Medicinal Chemistry LettersDOI: 10.1021/acsmedchemlett.2c00242

Source: ACS Medicinal Chemistry Letters - August 1, 2022 Category: Chemistry Authors: David Harrison, Mark G. Bock, John R. Doedens, Christopher A. Gabel, M. Katharine Holloway, Arwel Lewis, Jane Scanlon, Andrew Sharpe, Iain D. Simpson, Pamela Smolak, Grant Wishart, and Alan P. Watt Source Type: research